The efficacy and acceptability of amineptine versus fluoxetine in major depression
- PMID: 9347391
- DOI: 10.1097/00004850-199707003-00006
The efficacy and acceptability of amineptine versus fluoxetine in major depression
Abstract
The temporal dimension, particularly anticipation, appears to be a very important component in the understanding of depressed patients. In a 90-day multicentre study, the efficacy and acceptability of amineptine and fluoxetine were compared in 169 patients with major depression. Comparison of the two antidepressants was based on double-blind methods, after random allocation of the treatments between two parallel groups. The two drugs did not differ over the whole course of the study, but the improvement in scores on day 4 was globally more marked in the amineptine than the fluoxetine group. Intragroup analysis showed that amineptine was significantly superior to fluoxetine on the retardation pole of the mood, anxiety, retardation, danger scale. The positive effect of amineptine on anticipation may enable the depressed patient to make plans for the future. Anticipation may be a key dimension to be more precisely explored in specific psychopharmacological protocols with antidepressants.
Similar articles
-
A double-blind comparison of moclobemide and amineptine in the treatment of depressed out-patients.Psychopharmacology (Berl). 1992;106 Suppl:S116-7. doi: 10.1007/BF02246252. Psychopharmacology (Berl). 1992. PMID: 1546123 Clinical Trial.
-
Fluoxetine versus amineptine in the treatment of outpatients with major depressive disorders.Int Clin Psychopharmacol. 1989 Jan;4 Suppl 1:97-101. Int Clin Psychopharmacol. 1989. PMID: 2644344 Clinical Trial.
-
[Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression].Encephale. 1992 May-Jun;18(3):257-62. Encephale. 1992. PMID: 1299597 Clinical Trial. French.
-
Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.Depress Anxiety. 1996-1997;4(6):294-311. doi: 10.1002/(SICI)1520-6394(1996)4:6<294::AID-DA6>3.0.CO;2-C. Depress Anxiety. 1996. PMID: 9166658 Review.
-
[Therapeutic action lag time and resistance to treatment].Encephale. 1999 Jun;25 Spec No 2:49-54. Encephale. 1999. PMID: 10434159 Review. French.
Cited by
-
Fluoxetine versus other types of pharmacotherapy for depression.Cochrane Database Syst Rev. 2013 Jul 17;2013(7):CD004185. doi: 10.1002/14651858.CD004185.pub3. Cochrane Database Syst Rev. 2013. PMID: 24353997 Free PMC article.
-
Fluoxetine versus other types of pharmacotherapy for depression.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. doi: 10.1002/14651858.CD004185.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2013 Jul 17;(7):CD004185. doi: 10.1002/14651858.CD004185.pub3. PMID: 16235353 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources